Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW May 4, 2026 8:01 AM Eastern Daylight Time Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW Share -- Data support potentially best-in-class profile of XmAb942, under evaluation in ongoing global Phase 2b XENITH-UC study on track for 12-week induction results in 2027 -- -- Novel XenLockâ"¢ format optimizes bispecifics for treatment of autoimmune diseases; first XenLockâ"¢ candidate XmAb412 first-in-h ...